$32.71
+0.78 (+2.44%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Price Target
Analyst Price Target
+53.4% upside
Low Target
$29.72
Average Target
$50.17
High Target
$68.67
Current Price
$32.71
Current
$32.71
$32.71
Target
$50.17
$50.17
$29.72
$50.17 avg
$68.67
Scenario Analysis
Bear Case
$29.72
-9.1%
Low target
Base Case
$50.17
+53.4%
Avg target
Bull Case
$68.67
+109.9%
High target
Risk/Reward
12.0x
Highly favorable
Price in Context
52-Week High
$40.22
-18.7% from high
52-Week Low
$12.75
+156.5% from low
Target vs 52W High
$50.17
+24.7% vs high
Next Earnings Report
Aug 10, 2026
1d
tomorrow
EPS Est: $-0.81
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -11.6% |
| REGN | Buy | 38 | 71% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 44 | 64% | $91.45 | -56.0% |